# Novo Nordisk A/S - G8, X9 M.FI – FDA Inspection, Jun 16, 2022

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-g8-x9-mfi/a73b5e51-19ef-492f-93ba-175b269567c1
Source feed: FDA_Inspections

> FDA inspection 1297668 of Novo Nordisk A/S - G8, X9 M.FI, June 16, 2022. Classification: Voluntary Action Indicated (VAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1297668
- Company Name: Novo Nordisk A/S - G8, X9 M.FI
- Inspection Date: 2022-06-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1316850 - 2026-04-17](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-g8-x9-mfi/db3fab11-abbb-487e-b474-adf67f6e209f)
- FDA Inspection 1210000 - 2021-05-12
- FDA Inspection 1057701 - 2018-06-01
- FDA Inspection 965339 - 2016-04-14
- FDA Inspection 874067 - 2014-03-14

Company: https://www.keypedia.com/companies/novo-nordisk-as-g8-x9-mfi/389db4db-1347-40e5-88ef-284fdcfa1a1d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c